AMARIN CORP PLC\UK Income Taxes Paid
AMARIN CORP PLC\UK (AMRN) reported Income Taxes Paid of $5.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-04-29.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2021-04-29
- AMARIN CORP PLC\UK income taxes paid for the quarter ending 2021-03-31 was $5.00K.
- AMARIN CORP PLC\UK income taxes paid for the quarter ending 2020-12-31 was $10.00K.
- AMARIN CORP PLC\UK income taxes paid for the quarter ending 2020-09-30 was $177.00K, a 1006.25% increase year-over-year.
- AMARIN CORP PLC\UK income taxes paid for the quarter ending 2019-12-31 was -$20.00K, a 180.00% decline year-over-year.
- AMARIN CORP PLC\UK income taxes paid for fiscal 2020 was $207.00K, a 208.96% increase from fiscal 2019.
- AMARIN CORP PLC\UK income taxes paid for fiscal 2019 was $67.00K, a 92.12% decline from fiscal 2018.
- AMARIN CORP PLC\UK income taxes paid for fiscal 2018 was $850.00K, a 51.51% decline from fiscal 2017.
- AMARIN CORP PLC\UK income taxes paid for fiscal 2017 was $1.75M, a 20.32% increase from fiscal 2016.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2021-03-31 | $5.00K 10-Q · filed 2021-04-29 | $15.00K derived: sum of 2 quarters · filed 2021-04-29 | $192.00K derived: sum of 3 quarters · filed 2021-04-29 | |
| 2020-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $187.00K derived: sum of 2 quarters · filed 2021-02-25 | $207.00K 10-K · filed 2021-02-25 | |
| 2020-09-30 | $177.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $197.00K 10-Q · filed 2020-11-05 | ||
| 2020-06-30 | $20.00K 10-Q · filed 2020-08-04 | |||
| 2019-12-31 | -$20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$4.00K derived: sum of 2 quarters · filed 2021-02-25 | $67.00K 10-K · filed 2021-02-25 | |
| 2019-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $87.00K 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $71.00K 10-Q · filed 2020-08-04 | |||
| 2018-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $45.00K derived: sum of 2 quarters · filed 2021-02-25 | $827.00K derived: sum of 3 quarters · filed 2021-02-25 | $850.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $802.00K derived: sum of 2 quarters · filed 2019-11-05 | $825.00K 10-Q · filed 2019-11-05 | $1.39M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $782.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $805.00K 10-Q · filed 2019-07-31 | $1.37M derived: sum of 3 quarters · filed 2020-02-25 | $1.78M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $23.00K 10-Q · filed 2019-05-01 | $590.00K derived: sum of 2 quarters · filed 2020-02-25 | $998.00K derived: sum of 3 quarters · filed 2020-02-25 | $1.71M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $567.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $975.00K derived: sum of 2 quarters · filed 2020-02-25 | $1.69M derived: sum of 3 quarters · filed 2020-02-25 | $1.75M 10-K · filed 2020-02-25 |
| 2017-09-30 | $408.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.12M derived: sum of 2 quarters · filed 2018-11-01 | $1.19M 10-Q · filed 2018-11-01 | $1.55M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $714.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $778.00K 10-Q · filed 2018-08-01 | $1.14M derived: sum of 3 quarters · filed 2019-02-27 | $1.47M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $64.00K 10-Q · filed 2018-05-02 | $428.00K derived: sum of 2 quarters · filed 2019-02-27 | $754.00K derived: sum of 3 quarters · filed 2019-02-27 | $1.25M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $364.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $690.00K derived: sum of 2 quarters · filed 2019-02-27 | $1.19M derived: sum of 3 quarters · filed 2019-02-27 | $1.46M 10-K · filed 2019-02-27 |
| 2016-09-30 | $326.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $826.00K derived: sum of 2 quarters · filed 2017-11-01 | $1.09M 10-Q · filed 2017-11-01 | $1.28M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $767.00K 10-Q · filed 2017-08-02 | $952.00K derived: sum of 3 quarters · filed 2018-02-27 | $1.31M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $267.00K 10-Q · filed 2017-05-03 | $452.00K derived: sum of 2 quarters · filed 2018-02-27 | $807.00K derived: sum of 3 quarters · filed 2018-02-27 | $961.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $185.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $540.00K derived: sum of 2 quarters · filed 2018-02-27 | $694.00K derived: sum of 3 quarters · filed 2018-02-27 | $711.00K 10-K · filed 2018-02-27 |
| 2015-09-30 | $355.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $509.00K derived: sum of 2 quarters · filed 2016-11-03 | $526.00K 10-Q · filed 2016-11-03 | $726.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $154.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $171.00K 10-Q · filed 2016-08-04 | $371.00K derived: sum of 3 quarters · filed 2017-03-01 | $538.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $17.00K 10-Q · filed 2016-05-05 | $217.00K derived: sum of 2 quarters · filed 2017-03-01 | $384.00K derived: sum of 3 quarters · filed 2017-03-01 | $765.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $367.00K derived: sum of 2 quarters · filed 2017-03-01 | $748.00K derived: sum of 3 quarters · filed 2017-03-01 | $781.00K 10-K · filed 2017-03-01 |
| 2014-09-30 | $167.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $548.00K derived: sum of 2 quarters · filed 2015-11-04 | $581.00K 10-Q · filed 2015-11-04 | $581.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $381.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $414.00K 10-Q · filed 2015-08-06 | $414.00K derived: sum of 3 quarters · filed 2016-02-25 | $1.04M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $33.00K 10-Q · filed 2015-05-08 | $33.00K derived: sum of 2 quarters · filed 2016-02-25 | $663.00K derived: sum of 3 quarters · filed 2016-02-25 | $865.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $630.00K derived: sum of 2 quarters · filed 2016-02-25 | $832.00K derived: sum of 3 quarters · filed 2016-02-25 | $1.40M 10-K · filed 2016-02-25 |
| 2013-09-30 | $630.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $832.00K derived: sum of 2 quarters · filed 2014-11-06 | $1.40M 10-Q · filed 2014-11-06 | $1.82M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-06-30 | $202.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $765.00K 10-Q · filed 2014-08-07 | $1.19M derived: sum of 3 quarters · filed 2015-03-03 | $1.57M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-03-31 | $563.00K 10-Q · filed 2014-05-09 | $984.00K derived: sum of 2 quarters · filed 2015-03-03 | $1.37M derived: sum of 3 quarters · filed 2015-03-03 | $1.57M derived: sum of 4 quarters · filed 2015-03-03 |
| 2012-12-31 | $421.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $805.00K derived: sum of 2 quarters · filed 2015-03-03 | $1.01M derived: sum of 3 quarters · filed 2015-03-03 | $1.12M 10-K · filed 2015-03-03 |
| 2012-09-30 | $384.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $586.00K derived: sum of 2 quarters · filed 2013-11-07 | $697.00K 10-Q · filed 2013-11-07 | $877.00K derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $202.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $313.00K 10-Q · filed 2013-08-08 | $493.00K derived: sum of 3 quarters · filed 2014-02-27 | $664.00K derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $111.00K 10-Q · filed 2013-05-09 | $291.00K derived: sum of 2 quarters · filed 2014-02-27 | $462.00K derived: sum of 3 quarters · filed 2014-02-27 | $607.00K derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $180.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $351.00K derived: sum of 2 quarters · filed 2014-02-27 | $496.00K derived: sum of 3 quarters · filed 2014-02-27 | $761.00K 10-K · filed 2014-02-27 |
| 2011-09-30 | $171.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $316.00K derived: sum of 2 quarters · filed 2012-11-08 | $581.00K 10-Q · filed 2012-11-08 | $746.00K derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $145.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $410.00K 10-Q · filed 2012-08-08 | $575.00K derived: sum of 3 quarters · filed 2013-02-28 | $606.00K derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | $265.00K 10-Q · filed 2012-05-08 | $430.00K derived: sum of 2 quarters · filed 2013-02-28 | $461.00K derived: sum of 3 quarters · filed 2013-02-28 | |
| 2010-12-31 | $165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $196.00K derived: sum of 2 quarters · filed 2013-02-28 | $230.00K 10-K · filed 2013-02-28 | |
| 2010-09-30 | $31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $65.00K 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | $34.00K 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |